Prostate Cancer Drug May Slow Memory Loss in Alzheimer’s Patients

Prostate Cancer Drug May Slow Memory Loss in Alzheimer’s Patients
pillsA medication developed and commercialized for treating advanced prostate cancer may also help stabilize cognitive impairment in women who suffer from Alzheimer's disease, according to a study conducted at the University of Wisconsin-Madison and recently published at the Journal of Alzheimer's Disease. The research team analyzed a series of drug therapies, identifying one particular drug combination that could avoid cognitive impairment: Aricept and Lupron Depot. “This is the first time any therapy has been shown to stabilize memory loss over a year,” explained Dr. Craig Atwood, who is a co-lead author in the study and associated professor of medicine at the UW School of Medicine and Public Health, in a press release. The study "A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer's Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks", summarized t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *